Vertex Pharmaceuticals (VRTX) Cash from Investing Activities Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.24% |
| Dec 31, 2025 | -53.84% |
| Sep 30, 2025 | 32.72% |
| Jun 30, 2025 | -98.98% |
| Mar 31, 2025 | -3.04% |
| Dec 31, 2024 | -83.05% |
| Sep 30, 2024 | -87.37% |
| Jun 30, 2024 | -79.86% |
| Mar 31, 2024 | -206.36% |
| Dec 31, 2023 | -77.97% |
| Sep 30, 2023 | 21.99% |
| Jun 30, 2023 | -83.97% |
| Mar 31, 2023 | -291.28% |
| Dec 31, 2022 | 29.98% |
| Sep 30, 2022 | -15.55% |
| Jun 30, 2022 | -7.01% |
| Mar 31, 2022 | -9.23% |
| Dec 31, 2021 | -48.52% |
| Sep 30, 2021 | -1.97% |
| Jun 30, 2021 | 11.84% |
| Mar 31, 2021 | -157.44% |
| Dec 31, 2020 | 139.44% |
| Sep 30, 2020 | -3.25% |
| Jun 30, 2020 | 43.30% |
| Mar 31, 2020 | 29.99% |
| Dec 31, 2019 | -91.92% |
| Sep 30, 2019 | -109.21% |
| Jun 30, 2019 | 4.59% |
| Mar 31, 2019 | 27.50% |
| Dec 31, 2018 | 30.66% |
| Sep 30, 2018 | 20.93% |
| Jun 30, 2018 | -34.21% |
| Mar 31, 2018 | -71.54% |
| Dec 31, 2017 | -4.89% |
| Sep 30, 2017 | -110.86% |
| Jun 30, 2017 | -41.76% |
| Mar 31, 2017 | -99.07% |
| Dec 31, 2016 | 51.49% |
| Sep 30, 2016 | -11.11% |
| Jun 30, 2016 | -130.95% |
| Mar 31, 2016 | -39.79% |
| Dec 31, 2015 | -167.52% |
| Sep 30, 2015 | 8.38% |
| Jun 30, 2015 | 81.46% |
| Mar 31, 2015 | 42.99% |
| Dec 31, 2014 | 64.05% |
| Sep 30, 2014 | 12.51% |
| Mar 31, 2014 | -27.04% |
| Dec 31, 2013 | 10.96% |
| Sep 30, 2013 | 182.40% |
| Jun 30, 2013 | -28.37% |
| Mar 31, 2013 | -31.44% |
| Dec 31, 2012 | 26.27% |
| Sep 30, 2012 | -71.97% |
| Jun 30, 2012 | 5.75% |
| Mar 31, 2012 | -69.73% |